Novo Nordisk A/SNVONYSE
Loading
Revenue minus cost of goods sold
3Y CAGR
+17.2%/yr
vs +12.0%/yr prior
5Y CAGR
+17.6%/yr
Consistent
Acceleration
+5.1pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $238.77B | -2.9% |
| 2024 | $245.88B | +25.1% |
| 2023 | $196.50B | +32.3% |
| 2022 | $148.51B | +26.8% |
| 2021 | $117.14B | +10.5% |
| 2020 | $106.01B | +4.0% |
| 2019 | $101.93B | +8.2% |
| 2018 | $94.21B | +0.2% |
| 2017 | $94.06B | -0.6% |
| 2016 | $94.60B | - |